Heavy/light chain assay as a biomarker for diagnosis and follow-up of multiple myeloma

Conclusion In this study of a cohort of 176 patients in a routine clinical setting, we have provided evidence of the clinical utility of real world HLC assays for the identification of M-proteins and to monitor M-proteins with an emphasis on IgA monoclonal gammopathies.

Source: Clinica Chimica Acta - January 9, 2018 Category: Laboratory Medicine Source Type: research